CompanionMx is a digital mental health technology company that stands out with its platform called Companion, which proactively provides mobile mental health monitoring and supports clinical decision making. Similar to continuous blood glucometers for Type 1 diabetes patients, this platform offers clinicians a continuous, objective view of the patient's most current behavioral health state. This, for the first time ever, allows for an objective patient behavioral health assessment, enabling better care. The company's clinically validated results include assisting clinicians in predicting the onset of manic episodes up to two weeks in advance of symptoms getting reported and delivering more than 2x better outcomes compared to standard care. CompanionMx was founded in 2018 and operates in the Biotechnology, Health Care, and Mobile sectors. Though the current headquarters location and the details of the last investment are not available, the company's mission of using technology to improve mental health care is aligned with the growing focus on advancing healthcare solutions. With its innovative approach and proven results, CompanionMx presents a compelling opportunity for potential investors seeking to support technological innovations in the mental health space. As the demand for mental health solutions continues to rise, CompanionMx has the potential to make a significant impact on the industry and the well-being of numerous individuals.
There is no investment information
No recent news or press coverage available for CompanionMx.